• 1
    Fattovich G. Natural course and prognosis of chronic hepatitis type B. Viral Hep Rev 1996; 2: 263276.
  • 2
    Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH. Long-term remission of chronic hepatitis B after alpha-inter-feron therapy. Ann Intern Med 1991; 114: 629634.
  • 3
    Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heath-cote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993; 119: 312323.
  • 4
    Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336: 347356.
  • 5
    Niederau C, Heintges T, Lange S, Goldmann G, Niederau CM, Mohr L, Haussinger D. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996; 334: 14221427.
  • 6
    Realdi G, Fattovich G, Hadziyannis S, Schalm SW, Almasio P, Sanchez-Tapias J, Christensen E, et al. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. J Hepa-tol 1994; 21: 656666.
  • 7
    Fattovich G, Giustina G, Schalm SW, Hadziyannis S, Sanchez-Tapias J, Almasio P, Christensen E, et al. Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B. Hepatology 1995; 21: 7782.
  • 8
    Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology. A basic science for clinical medicine. Boston: Little, Brown and Company, 1991.
  • 9
    Infante-Rivard C, Villeneuve JP, Esnaola S. A framework for evaluating and conducting prognostic studies: an application to cirrhosis of the liver. J Clin Epidemiol 1989; 42: 791805.
  • 10
    Bianchi L, De Groote J, Desmet VJ, Gedik P, Korb G, Popper H, Poulsen H, et al. Acute and chronic hepatitis revisited. Lancet 1977; 2: 914919.
  • 11
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457481.
  • 12
    Peto R, Pike MC. Conservatism of the approximation (0-E)/E in the logrank test for survival data on tumor incidence data. Biometrics 1973; 29: 579584.
  • 13
    Cox DR. Regression models and life tables [with discussion]. J R Stat SocB 1972; 34: 187220.
  • 14
    Krogsgaard K, Christensen E, Bindslev N, Schalm S, Andersen PK, Ring-Larsen H, and the European Concerted Action on Viral Hepatitis (Euro-hep). Relation between treatment efficacy and cumulative dose of alpha interferon in chronic hepatitis B. J Hepatol 1996; 25: 795802.
  • 15
    Popper H, Shafritz DA, Hoofnagle JH. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology 1987; 7: 764772.